← Browse by Condition
Medical Condition

refractory hodgkin lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06484920 Phase 2
Recruiting

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

Enrollment
24 pts
Location
United States
Sponsor
Rita Assi
View Trial →